IMPACT OF TREATMENT ADMINISTRATION ON SELECTION OF BCR-ABL1 KINASE DOMAIN MUTATIONS

被引:0
|
作者
Razga, F. [1 ]
Jurcek, T. [1 ]
Zackova, D. [1 ]
Dvorakova, D. [1 ,2 ]
Toskova, M. [1 ]
Jeziskova, I. [1 ]
Mayer, J. [1 ,2 ]
Racil, Z. [1 ,2 ]
机构
[1] Univ Hosp Brno, Brno, Czech Republic
[2] Masaryk Univ Brno, CEITEC, Brno, Czech Republic
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1326
引用
收藏
页码:536 / 537
页数:2
相关论文
共 50 条
  • [1] Role of Treatment in the Appearance and Selection of BCR-ABL1 Kinase Domain Mutations
    Filip Razga
    Tomas Jurcek
    Daniela Zackova
    Dana Dvorakova
    Martina Toskova
    Ivana Jeziskova
    Jiri Mayer
    Zdenek Racil
    Molecular Diagnosis & Therapy, 2012, 16 : 251 - 259
  • [2] Role of Treatment in the Appearance and Selection of BCR-ABL1 Kinase Domain Mutations
    Razga, Filip
    Jurcek, Tomas
    Zackova, Daniela
    Dvorakova, Dana
    Toskova, Martina
    Jeziskova, Ivana
    Mayer, Jiri
    Racil, Zdenek
    MOLECULAR DIAGNOSIS & THERAPY, 2012, 16 (04) : 251 - 259
  • [3] BCR-ABL1 kinase domain mutations: Methodology and clinical evaluation
    Alikian, Mary
    Gerrard, Gareth
    Subramanian, Papagudi G.
    Mudge, Katherine
    Foskett, Pierre
    Khorashad, Jamshid Sorouri
    Lim, Ai Chiin
    Marin, David
    Milojkovic, Dragana
    Reid, Alistair
    Rezvani, Katy
    Goldman, John
    Apperley, Jane
    Foroni, Letizia
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 298 - 304
  • [4] Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
    Soverini, Simona
    de Benedittis, Caterina
    Mancini, Manuela
    Martinelli, Giovanni
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S120 - S128
  • [5] Detection of ABL1 kinase Domain Mutations in Therapy Naive BCR-ABL1 Positive ALL
    Baer, Constance Regina
    Meggendorfer, Manja
    Haferlach, Claudia
    Kern, Wolfgang
    Haferlach, Torsten
    BLOOD, 2017, 130
  • [6] Detection and Monitoring of BCR-ABL1 Kinase Domain Mutations By Next Generation Sequencing
    Vannuffel, Pascal
    Cauwelier, Barbara
    De Rop, Celine
    Nollet, Friedel
    BLOOD, 2015, 126 (23)
  • [7] Reflexive Screening for BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Langabeer, Stephen E.
    McCarron, Sarah L.
    Haslam, Karl
    Preston, Lisa
    CLINICAL LABORATORY, 2016, 62 (05) : 975 - 976
  • [8] A Novel BCR-ABL1 Degrader, Ubx-362, Can Overcome Resistance By BCR-ABL1 Kinase Domain Mutations in Chronic Myeloid Leukemia
    Lim, Ye Seul
    Jeong, Na-Rae
    Yoo, Sun-Mi
    Kim, Han Wool
    Lee, Song Hee
    Kim, Dong-Wook
    BLOOD, 2023, 142
  • [9] STUDY OF MUTATIONS IN THE KINASE DOMAIN OF BCR-ABL1 BY NGS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Stuckey, Ruth
    Florido, Ortega Yanira
    Rodriguez, Lopez Juan Francisco
    Bilbao, Sieyro Cristina
    Gomez, Casares Maria Teresa
    HAEMATOLOGICA, 2020, 105 : 239 - 239
  • [10] Clonal Evolution of BCR-ABL1 Kinase Domain Mutation In Tyrosine Kinase Inhibitor Treatment Patient
    Liu, Hongxing
    Zhu, Ping
    Tong, Chunrong
    Zhao, Yanli
    Cai, Peng
    Zhu, Juan
    Wang, Fang
    Gu, Jiangying
    Xie, Jianjun
    Zhang, Xian
    Lu, Dao-Pei
    BLOOD, 2010, 116 (21) : 263 - 263